1.Wang X, Wu X, Tan B, Zhu L, Zhang Y, Lin L, Xiao Y, Sun A, Wan X, Liu S, Liu Y, Ta N, Zhang H, Song J, Li T, Zhou L, Yin J, Ye L, Lu H, Hong J, Cheng H, Wang P, Li W, Chen J, Zhang J, Luo J, Huang M, Guo L, Pan X, Jin Y, Ye W, Dai L, Zhu J, Sun L, Zheng B, Li D, He Y, Liu M, Wu H, Du B, Xu H. (2024).Allogeneic CD19-targeted CAR-T therapy in severe myositis and systemic sclerosis achieved durable remission and reversed extensive fibrotic damages. Cell. doi: 10.1016/j.cell.2024.06.027
2.Wang T, Sternes PR, Guo XK, Zhao H, Xu C, Xu H. (2024). Autoimmune diseases exhibit shared alterations in the gut microbiota. Rheumatology. 63, 856-865.
3.Liu Y, Zhang Z, Kang Z, Zhou X, Liu S, Guo S, Jin Q, Li T, Zhou L, Wu X, Wang YN, Lu L, He Y, Li F, Zhang H, Liu Y, Xu H. (2023). Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus. Ann Rheum Dis. 82, 1444-1454
4.Li JX, Wu X, Lee YH, Xu H. (2023). West Meets East in Genetics of Ankylosing Spondylitis. Int J Rheum Dis. 26, 2122-2126
5.Guo XK, Wang J, Vincent P. H, Liu J, Xu H, Hu X. (2023). Interactions between host and intestinal crypt-resided biofilms are controlled by epithelial fucosylation. Cell Rep. 42, 112754
6.Kang Z, Wang J, Meng T, Zhang H, Xu D, Gong H, Chang Z, Li Z, Cui X, Xiao J, Qureshi AI., Zhou W, Liu J, Xu H. (2023). Pericytes may facilitate SARS-CoV-2 entry into the nervous system. Journal of Bio-X Research. 6, 23-36
7.Tian H, Li T, Wang Y, Lu H, Lin L, Wu X, Xu H. (2023). The correlations between C-reactive protein and MRI-detected inflammation in patients with axial spondyloarthritis: a systematic review and meta-analysis. Clin Rheumatol. 42, 2397-2407
8.Cai B, Lu H, Ye Q, Xiao Q, Wu X, Xu H. (2023). Identification of potent target and its mechanism of action of Tripterygium wilfordii Hook F in the treatment of lupus nephritis. Int J Rheum Dis. 26, 1529-1539
9.Li Y, Li B, Wang G, Su J, Qiao Y, Ma C, Wang F, Zhu J, Li J, Zhang H, Liu K, Xu H. (2023). Engineered protein and Jakinib nanoplatform with extraordinary rheumatoid arthritis treatment. Nano Res. 16, 11197−11205
10.Wang X, Zhu L, Ying S, Liao X, Zheng J, Liu Z, Gao J, Niu M, Xu X, Zhou Z, Xu H. (2023). Increased RNA Editing Sites Revealed as Potential Novel Biomarkers for Diagnosis in Primary Sjögren’s Syndrome. J Autoimmun. 138, 103035
11.Jin Q, Liu Y, Zhang Z, We X, Chen Z, Tian H, Kang Z, Wu X, Xu H. (2023). MYC Promotes Fibroblast Osteogenesis by Regulating ALP and BMP2 to Participate in Ectopic Ossification of Ankylosing Spondylitis. Arthritis Res Ther. 25, 28
12.Chi X, Huang M, Tu H, Zhang B, Lin X, Xu H, Dong C, Hu X. (2023). Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections. Sci China Life Sci. 66, 1482-1517.
13.Heijde D, Deodhar A, Baraliakos X, Brown MA, Dobashi H, Dougados M, Elewaut D, Ellis AM, Fleurinck C, Gaffney K, Gensler LS, Haroon N, Magrey M, Maksymowych WP, Marten A, Massow U, Oortgiesen M, Poddubnyy D, Rudwaleit M, Shepherd-Smith J, Tomita T, Bosch F, Vaux T, Xu H. (2023). Efficacy and Safety of Bimekizumab in Axial Spondyloarthritis: Results of Two Parallel Phase 3 Randomized Controlled Trials. Ann Rheum Dis. 82, 515-526
14.Huang M, Xu H. (2022). Genetic susceptibility to autoimmunity-current status and challenges. Adv Immunol. 156, 25-54
15.Ye L, Li W F, Shao J, Xu Z, Ju J, Xu H. (2022). Fighting Omicron epidemic in China: real-world big data from Fangcang Shelter Hospital during the outbreak in Shanghai 2022. J Infection. 85, 436-480
16.Wu X, Geng X, Shang Z, Wang Z, Lu H, Liu W, Xu H. (2022). Post-traumatic stress disorder in patients with rheumatic disease during the COVID-19 outbreak: a cross-sectional case-control study in China. BMJ Open. 12, e049749.
17.Wu X, Xu H, Dong C. (2022). Beyond interleukin-17-targeted therapy: Complexity of environment-genetics-immunology needs to be addressed. Chinese Med J-Peking. 135, 511-512
18.Ye L, Zhou L, Bian J, Zhao J, Li T, Wu X, Xu H. (2022). Disease activity guided stepwise tapering but not discontinuation of biologics is a feasible therapeutic strategy for patients with ankylosing spondylitis: real-world evidence. Adv Ther. 39, 1393-1402
19.Wang T, Guo X K, Xu H. (2021). Disentangling the progression of nonalcoholic fatty liver disease in the human gut microbiota. Front Microbiol. 12, 728823
20.Lu H, Wang Y, Wang X, Wu X, Zhou L, Sheng R, Tian H, Li T, Xu H. (2021). Yisaipu® provide AS patients with an economical therapeutic option while original biologicals are more advantageous in the COVID-19 epidemic situation. Front Pharmacol. 12, 692768
21.Zhou L, Li T, Wu X, Lu H, Lin L, Ye L, Yin J, Zhao J, Wang X, Bian J, Xu H. (2021). Assessment of neuropathic pain in Ankylosing Spondylitis: prevalance and characteristics. Pain Ther. 10, 1467-1479
22.Wu X, Wang G, Zhang L, Xu H. (2021). Genetics of Ankylosing Spondylitis – focusing on the ethnic difference between East Asia and Europe. Front Genet. 12, 671682
23.Li Z, Wu X, Leo PJ, Guzma L, Akkoc N, Breban M, MacFarlane G, Mahmoudi M,Marzo-Ortega H, Anderson L, Wheeler L, Chou CT, Harrison AA, Stebbings S, Jones GT, Bang SO, Wang G, Song J, Lin L, Li M, Wei JZZ, Martin NG, Wright MJ, Lee M, Wang Y, Zhan J, Zhang JS, Wang XB, Jin ZB, Weisman MH, Gensler LS, Ward MM, Rahbar MH, Diekman L, Kim T, Reveille JD, Wordsworth PB, Xu H, Brown MA. (2021). Polygenic risk scores have high diagnostic capacity in ankylosing spondylitis. Ann Rheum Dis. 80, 1168-1174
24.Brown MA, Xu H, Li Z. (2020). Genetics and the axial spondyloarthritis spectrum. Rheumatology. 59, iv58-iv66
25.Wu X, Zheng H, wang C, Xu S, Gao G, Li M, Wang Z, Jiang C, Dou Z, Xiao Y, Xie K, Wang S, Xu H. (2020). A novel privacy-preserving federated genome-wide association study framework and its application in identifying potential risk variants in ankylosing spondylitis. Brief Bioinfirm. 22, bbaa090
26.Zhang H, Kang Z, Gong H, Xu D, Wang J, Li ZX, Li ZF, Cui XG, Xiao JR, Zhan J, Meng T, Zhou W, Liu JM, Xu H. (2020). Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 69, 1010-1018
27.Wang G, Kim TH, Li ZX, Cortes.A, Kim K, Bang SY, Leo P, Brown MA, Xu H. (2020). MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions. Arthritis Res Ther. 22, 74
28.Shi XY, Wang G, Li T, Li Z, Leo P, Liu Z, Wu G, Zhu H, Zhang Y, Li D, Gao L, Yang L, Wang W, Liao J, Wang J, Zhou S, Wang H, Li X, Gao J, Zhang L, Shu X, Li D, Li Y, Chen C, Zhang X, Reutens D, Bartlett P, Brown MA, Zou LP, Xu H. (2020). Identification of susceptibility variants to benign childhood epilepsy with centro-temporal spikes (BECTS) in Chinese Han population. EBioMedicine. 57, 102840
29.Liu Y, Wu X, Ye L, Xu H. (2020). Successful treatment of a patient with kasabach–merritt syndrome and multiple giant hepatic hemangiomas. J Int Med Res. 48, 030006051989835
30.Xu H, Yin J. (2020). HLA risk alleles and gut microbiome in ankylosing spondylitis and rheumatoid arthritis. Best Pract Res CL RH. 33, 101499
31.Li T, Liu Y, Sheng R, Yin J, Wu X, Xu H. (2020). Correlation between chronic pain acceptance and clinical variables in ankylosing spondylitis and its prediction role for biologics treatment. Front Med (Lausanne). 7, 17
32.Yin J, Sternes P, Wang M, Song J, Morrison M, Li T, Zhou L, Wu X, He F, Zhu J, Brown MA, Xu H. (2020). Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition. Ann Rheum Dis. 79, 132-140
33.Zhang W, Zhang H, Liu S, Xia F, Kang Z , Zhang Y, Liu Y, Xiao H, Chen L , Huang C, Shen N, Xu H, Li F. (2019). Excessive CD11c(+)T bet(+) B cells promote aberrant T-FH differentiation and affinity-based germinal center selection in lupus. P Natl Acad Sci USA. 116, 18550-18560
34.Wu X, Lu H, Xu H. (2019). Andersson lesion in ankylosing spondylitis misdiagnosed as spinal tuberculosis: two cases. Int J Clin Exp Med. 12, 14001-14004
35.Li T, Zhou L, Zhao H, Song J, Wang X, Liu S, Xu H. (2019). Fatigue in ankylosing spondylitis is associated with the psychological factors and brain gray matter. Front Med (Lausanne). 6, 271
36.Xu H, Li Z, Wu J, Xing Q, Shi G, Li J, Liu X, Wu L, Li X, Tan W, He D, Bi L, Li H, Xiao Z, Shuai Z, Li X, Wang Y, Luo L, Zheng Y, Xiao W, Wu X, Zhou L, Li T, Qian L, Zhou H, Lu S, Zheng S, Xiong Y, Wang X, Wang Y, Wu X. (2019). IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: a randomized, double-blind, phase 3 equivalence trial. Lancet Rheum. 1, e35–43
37.Liu Y, Zhang Z, Jin Q, Liu Y, Kang Z, Huo Y, He Z, Feng X, Yin J, Wu X, Wang H, Xu H. (2019). Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B cell subsets. Endocrine. 64, 648-656
38.Khanniche A, Zhou L, Jiang B, Song J, Jin Y, Yin J, Wang S, Ji P, Shen H, Wang Y, Xu H. (2019). Restored and enhanced memory T cell immunity in rheumatoid arthritis after TNFα blocker treatment. Front Immunol. 10, 887
39.Wu X, Sheng X, Sheng R, Lu H, Xu H. (2019). Genetic and clinical markers for predicting treatment responsiveness in rheumatoid arthritis. Frontiers of Medicine. 13, 411-419
Complete list of publications: https://www.scopus.com/authid/detail.uri?authorId=15078044400
https://www.webofscience.com/wos/author/record/AAB-2902-2021
